ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,639, issued on Aug. 18, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).

"Compositions and methods to treat or prevent metabolic fatigue using the compound oleuropein or a metabolite thereof" was invented by Umberto De Marchi (Corminboeuf, Switzerland), Marie Noelle Horcajada (Echenevex, France), Jerome Feige (Crissier, Switzerland), Cristina Mammucari (Padua, Italy) and Bert Blaauw (Padua, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "At least one of oleuropein or metabolite thereof can be orally administered to an individual in an amount effective to achieve at least one result that is one or more of (i) improvement in...